patientorientend.graduated.interdisciplinary.network-treatment - PAIN2.0

Deutsche Schmerzgesellschaft e.V.0 个研究点目标入组 1,350 人开始时间: 2022年11月21日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•(at least 6 weeks ago) newly occurring pain or pain that has occurred repeatedly or persisted for a longer period of time
•- pain-related restrictions relevant to the person affected (possibly already occurring AU, impairment in everyday life/family/leisure time and (home) work), as well as associated deterioration in the quality of life
•- a risk of chronification (e.g. spreading pain, stress factors in family and work, pronounced sparing and avoidance behavior):
•- Participants in the study are at least 18 years of age, have sufficient knowledge of written and spoken German, live within reach of the participating facility, and have given verbal and written consent to participate in advance.
•- Participants are insured with a GKV health insurance company.

•Primary exclusion criteria are clinical indications of a serious illness requiring urgent acute therapy red flags, or other acutely effective serious illnesses that prevent activating treatment (e.g. severe heart failure, tumor); a manifest chronic pain illness that has already occurred (e.g. AU due to pain for longer than 6 months, previous IMST in the last two years). (e.g., sick leave due to pain for more than 6 months, previous therapy with strong opioids lasting more than 6 months, previous IMST in the last two years); a severe and active psychiatric disorder (personality disorder, severe depression, indications of suicidal tendencies); an ongoing pension procedure or rehabilitation procedure planned in the near future; linguistic and/or cognitive impairments; ongoing diagnostics and/or therapy with regard to pain-specific pathology (in these cases, the result should first be awaited). Patients undergoing treatment under the terms of the employers' liability insurance association and with private health insurance are to be excluded.

发起方

Deutsche Schmerzgesellschaft e.V.